Condition: Bladder Cancer · Sponsor: University of Thessaly
The natural history of non-muscle-invasive bladder cancer is characterised by recurrence and progression. We compare the effectiveness of gemcitabine hydrochloride and epirubicin hydrochloride, in combination with continuous saline irrigation, as an immediate single intravesical instillation in the potential reduction of the disease recurrence as well as progression.
This description comes directly from the study's public registry record.
Vasileios Tzortzis, Professor · 00302413502811 · urologydpt.uth@gmail.com
Lampros Mitrakas, Consultant · 00302413501325 · lamprosmit@gmail.com
Always discuss trial participation with your own doctor first.
| Urology Department, University of Thessaly, University Hospital of Larissa | Larissa, Larissa/Thessaly, Greece | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04947059